George Thurber, MD
Ophthalmology · Ocean Springs, MSNPI 1194839779
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,693 of the $7,507 with a category attached, or 75.8%. 17 manufacturers reported payments, led by Johnson & Johnson Surgical Vision, Inc. at 52.3% of the total. Reporting peaked in 2019 at $2,868 and has fallen 85.9% since, to $404 in 2025.
Across 157 payments — averaging $47.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Surgical Vision, Inc.$4K
- AbbVie$1K
- Glaukos Corporation$1K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$328
- Bausch & Lomb Americas Inc.$265
- Mallinckrodt Hospital Products Inc.$133
- plus $508 from 11 others
What the payments were for
- Travel & lodging$1,71623%
- Food & beverage$5,69376%
- Education$981%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | 47 | $3,924 |
| AbbVie(2 entities) | 47 | $1,341 |
| Glaukos Corporation | 10 | $1,008 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 15 | $328 |
| Bausch & Lomb Americas Inc. | 10 | $265 |
| Mallinckrodt Hospital Products Inc. | 3 | $133 |
| Alcon | 6 | $114 |
| Aerie Pharmaceuticals, Inc. | 5 | $84 |
| Ocular Therapeutix, Inc. | 3 | $55 |
| Kala Pharmaceuticals, Inc. | 2 | $47 |
| Oyster Point Pharma, Inc. | 2 | $47 |
| Sight Sciences, Inc. | 2 | $43 |
| Rayner Intraocular Lenses Limited | 1 | $38 |
| Harrow Eye, LLC | 1 | $37 |
| Sun Pharmaceutical Industries Inc. | 1 | $23 |
| Novartis | 1 | $14 |
| NEW World Medical,inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tecnis 1-piece IOL$2,036
- Tecnis 3-piece IOL$2,036
- Tecnis Symphony IOL$2,036
- Tecnis Symphony Toric IOL$2,036
- Tecnis IOL$719
- Photrexa$292
- DURYSTA$226
- CATALYS SYSTEM$211
- iStent Trabecular Micro-Bypass System Model iS3$194
- iDoseTR$189
- TECNIS Presbyopia-Correcting IOLs$124
- XEN GLAUCOMA TREATMENT SYSTEM$120
- MIEBO$112
- Catalyst System$111
- BESIVANCE$104
How this compares
$7,507 in reported general payments places this provider in the 85th percentile of 150 ophthalmology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 61 | $34,504 |
| CombiganBrimonidine Tartrate/Timolol | 64 | $19,866 |
| RestasisCyclosporine | 23 | $16,678 |
| RocklatanNetarsudil Mesylat/Latanoprost | 15 | $8,627 |
| Latanoprost | 871 | $7,640 |
| Travoprost | 37 | $5,928 |
| Prednisolone Acetate | 163 | $5,161 |
| Timolol Maleate | 191 | $5,066 |
| Lotemax SmLoteprednol Etabonate | 17 | $4,166 |
| Ketorolac Tromethamine | 50 | $1,965 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 15 | $1,611 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 58 | $944 |
| Acetazolamide | 174 | $623 |
| Ofloxacin | 52 | $601 |
| Dorzolamide Hcl | 29 | $574 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLumigan, Combigan, Restasis | $1,341 | $71,048148 claims |
| Aerie Pharmaceuticals, Inc.Rocklatan | $84 | $8,62715 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCLotemax Sm | $328 | $4,16617 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 150 ophthalmology providers in Mississippi.
Other ophthalmology in Ocean Springs
- Blake MatherneOcean Springs$5K
- Larry FerdinandOcean Springs$4K
- Debra LapradOcean Springs$4K
- James SuttonOcean Springs$3K
- Kiper NelsonHattiesburg$234K
- John ParkerTupelo$72K
- Joseph ChildsTupelo$42K
- Heather HancockJackson$39K
- Leslie AdenFlowood$38K
- Adam QuinnHattiesburg$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.